The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Hoelscher Paul W. since 2015.
This trader's CIK number is 1611468.
At the time of last reporting, Hoelscher Paul W. was the EVP, CFO of Horizon Therapeutics Public Ltd Co. (stock ticker symbol HZNP).
Also see all insider trading activities at Horizon Therapeutics Public Ltd Co.
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2022 | HZNP | 0 | $0 | 396,978 | $43,909,164 | 363,805 | $5,625,527 |
2021 | HZNP | 0 | $0 | 8,575 | $943,250 | 112,323 | $136,857 |
2020 | HZNP | 0 | $0 | 134,570 | $6,236,956 | 83,678 | $0 |
2019 | HZNP | 0 | $0 | 92,262 | $2,583,790 | 126,271 | $563,422 |
2018 | HZNP | 0 | $0 | 0 | $0 | 51,000 | $0 |
2017 | HZNP | 0 | $0 | 0 | $0 | 51,000 | $0 |
2016 | HZNP | 0 | $0 | 0 | $0 | 51,000 | $0 |
2015 | HZNP | 0 | $0 | 0 | $0 | 20,000 | $0 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2022-04-20 | HZNP | Option Ex | 50,000 | 22.14 | 1,107,000 |
2022-04-20 | HZNP | Sale | 50,000 | 114.77 | 5,738,250 |
2022-04-06 | HZNP | Option Ex | 215,335 | 19.05 | 4,102,131 |
2022-04-06 | HZNP | Sale | 307,045 | 110.01 | 33,778,020 |
2022-03-25 | HZNP | Sale | 663 | 110.00 | 72,930 |
2022-03-24 | HZNP | Sale | 1,481 | 110.00 | 162,910 |
2022-03-23 | HZNP | Sale | 37,789 | 110.01 | 4,157,054 |
2022-03-23 | HZNP | Option Ex | 26,090 | 15.96 | 416,396 |
2022-01-21 | HZNP | Option Ex | 5,558 | .00 | 0 |
2022-01-05 | HZNP | Option Ex | 66,822 | .00 | 0 |
2021-12-28 | HZNP | Option Ex | 8,575 | 15.96 | 136,857 |
2021-12-28 | HZNP | Sale | 8,575 | 110.00 | 943,250 |
2021-01-21 | HZNP | Option Ex | 5,556 | .00 | 0 |
2021-01-05 | HZNP | Option Ex | 98,192 | .00 | 0 |
2020-08-24 | HZNP | Sale | 29,576 | 75.98 | 2,247,184 |
2020-05-05 | HZNP | Sale | 104,994 | 38.00 | 3,989,772 |
2020-01-05 | HZNP | Option Ex | 83,678 | .00 | 0 |
2019-10-15 | HZNP | Sale | 20,000 | 28.00 | 560,100 |
2019-08-30 | HZNP | Sale | 1,359 | 28.00 | 38,052 |
2019-08-22 | HZNP | Option Ex | 29,576 | 19.05 | 563,422 |
2019-08-21 | HZNP | Sale | 70,903 | 28.00 | 1,985,638 |
2019-03-23 | HZNP | Option Ex | 31,000 | .00 | 0 |
2019-01-05 | HZNP | Option Ex | 65,695 | .00 | 0 |
2018-06-23 | HZNP | Option Ex | 20,000 | .00 | 0 |
2018-03-23 | HZNP | Option Ex | 31,000 | .00 | 0 |
2017-06-23 | HZNP | Option Ex | 20,000 | .00 | 0 |
2017-03-23 | HZNP | Option Ex | 31,000 | .00 | 0 |
2016-06-23 | HZNP | Option Ex | 20,000 | .00 | 0 |
2016-03-23 | HZNP | Option Ex | 31,000 | .00 | 0 |
2015-06-23 | HZNP | Option Ex | 20,000 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hoelscher Paul W. (EVP, CFO of Horizon Therapeutics Public Ltd Co at the time of this reporting) see the Securities and Exchange Commission (SEC) website.